211 related articles for article (PubMed ID: 37020038)
1. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
[TBL] [Abstract][Full Text] [Related]
2. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
3. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
4. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
5. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
6. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
Federico A; Thomas C; Miskiewicz K; Woltering N; Zin F; Nemes K; Bison B; Johann PD; Hawes D; Bens S; Kordes U; Albrecht S; Dohmen H; Hauser P; Keyvani K; van Landeghem FKH; Lund EL; Scheie D; Mawrin C; Monoranu CM; Parm Ulhøi B; Pietsch T; Reinhard H; Riemenschneider MJ; Sehested A; Sumerauer D; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Acta Neuropathol; 2022 Jun; 143(6):697-711. PubMed ID: 35501487
[TBL] [Abstract][Full Text] [Related]
7. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
9. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR; Lu M; Chan TS; Picard D; de Antonellis P; Khuong-Quang DA; Planello AC; Zeller C; Barsyte-Lovejoy D; Lafay-Cousin L; Letourneau L; Bourgey M; Yu M; Gendoo DMA; Dzamba M; Barszczyk M; Medina T; Riemenschneider AN; Morrissy AS; Ra YS; Ramaswamy V; Remke M; Dunham CP; Yip S; Ng HK; Lu JQ; Mehta V; Albrecht S; Pimentel J; Chan JA; Somers GR; Faria CC; Roque L; Fouladi M; Hoffman LM; Moore AS; Wang Y; Choi SA; Hansford JR; Catchpoole D; Birks DK; Foreman NK; Strother D; Klekner A; Bognár L; Garami M; Hauser P; Hortobágyi T; Wilson B; Hukin J; Carret AS; Van Meter TE; Hwang EI; Gajjar A; Chiou SH; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheinemann K; Fleming AJ; Johnston DL; Michaud J; Zelcer S; Hammond R; Afzal S; Ramsay DA; Sirachainan N; Hongeng S; Larbcharoensub N; Grundy RG; Lulla RR; Fangusaro JR; Druker H; Bartels U; Grant R; Malkin D; McGlade CJ; Nicolaides T; Tihan T; Phillips J; Majewski J; Montpetit A; Bourque G; Bader GD; Reddy AT; Gillespie GY; Warmuth-Metz M; Rutkowski S; Tabori U; Lupien M; Brudno M; Schüller U; Pietsch T; Judkins AR; Hawkins CE; Bouffet E; Kim SK; Dirks PB; Taylor MD; Erdreich-Epstein A; Arrowsmith CH; De Carvalho DD; Rutka JT; Jabado N; Huang A
Cancer Cell; 2016 Dec; 30(6):891-908. PubMed ID: 27960086
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
[TBL] [Abstract][Full Text] [Related]
11. Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
Ho B; Johann PD; Grabovska Y; De Dieu Andrianteranagna MJ; Yao F; Frühwald M; Hasselblatt M; Bourdeaut F; Williamson D; Huang A; Kool M
Neuro Oncol; 2020 May; 22(5):613-624. PubMed ID: 31889194
[TBL] [Abstract][Full Text] [Related]
12. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
[TBL] [Abstract][Full Text] [Related]
13. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
Hoffman LM; Richardson EA; Ho B; Margol A; Reddy A; Lafay-Cousin L; Chi S; Slavc I; Judkins A; Hasselblatt M; Bourdeaut F; Frühwald MC; Vibhakar R; Bouffet E; Huang A
Neuro Oncol; 2020 Jul; 22(7):944-954. PubMed ID: 32129445
[TBL] [Abstract][Full Text] [Related]
14. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.
Johann PD; Erkek S; Zapatka M; Kerl K; Buchhalter I; Hovestadt V; Jones DTW; Sturm D; Hermann C; Segura Wang M; Korshunov A; Rhyzova M; Gröbner S; Brabetz S; Chavez L; Bens S; Gröschel S; Kratochwil F; Wittmann A; Sieber L; Geörg C; Wolf S; Beck K; Oyen F; Capper D; van Sluis P; Volckmann R; Koster J; Versteeg R; von Deimling A; Milde T; Witt O; Kulozik AE; Ebinger M; Shalaby T; Grotzer M; Sumerauer D; Zamecnik J; Mora J; Jabado N; Taylor MD; Huang A; Aronica E; Bertoni A; Radlwimmer B; Pietsch T; Schüller U; Schneppenheim R; Northcott PA; Korbel JO; Siebert R; Frühwald MC; Lichter P; Eils R; Gajjar A; Hasselblatt M; Pfister SM; Kool M
Cancer Cell; 2016 Mar; 29(3):379-393. PubMed ID: 26923874
[TBL] [Abstract][Full Text] [Related]
15. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
[TBL] [Abstract][Full Text] [Related]
16. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
17. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
19. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
[TBL] [Abstract][Full Text] [Related]
20. Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics.
Nesvick CL; Lafay-Cousin L; Raghunathan A; Bouffet E; Huang AA; Daniels DJ
J Neurooncol; 2020 Oct; 150(1):47-56. PubMed ID: 33021733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
